Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Translational medication development for nicotine addiction.

Morgan G, Backinger C, Lerman C, Vocci F.

Am J Health Behav. 2010 May-Jun;34(3):267-74.

PMID:
20001184
2.

Treating tobacco dependence: state of the science and new directions.

Lerman C, Patterson F, Berrettini W.

J Clin Oncol. 2005 Jan 10;23(2):311-23. Review.

PMID:
15637394
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Tobacco dependence. Global public health potential for new medications development and indications.

Henningfield JE, Fant RV, Gitchell J, Shiffman S.

Ann N Y Acad Sci. 2000;909:247-56. Review.

PMID:
10911934
5.

Current and emerging pharmacotherapies for treating tobacco dependence.

Schnoll RA, Lerman C.

Expert Opin Emerg Drugs. 2006 Sep;11(3):429-44. Review.

PMID:
16939383
6.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

7.

Translating basic science to improve pharmacotherapy for nicotine dependence.

Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C.

Nicotine Tob Res. 2007 Nov;9 Suppl 4:S583-98. doi: 10.1080/14622200701691755. Review.

PMID:
18067034
8.

State Medicaid coverage for tobacco-dependence treatments--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 8;57(5):117-22.

9.
10.

Tobacco addiction: implications for treatment and cancer prevention.

Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS.

J Natl Cancer Inst. 1997 Dec 17;89(24):1852-67. Review.

PMID:
9414173
11.

New horizons for therapeutics in drug and alcohol abuse.

Jupp B, Lawrence AJ.

Pharmacol Ther. 2010 Jan;125(1):138-68. doi: 10.1016/j.pharmthera.2009.11.002. Epub 2009 Nov 14. Review.

PMID:
19917308
12.

Non-nicotine pharmacotherapy for smoking cessation.

Ferry LH.

Prim Care. 1999 Sep;26(3):653-69. Review.

PMID:
10436292
13.

Pharmacologic treatments for drug and alcohol dependence.

Kranzler HR, Amin H, Modesto-Lowe V, Oncken C.

Psychiatr Clin North Am. 1999 Jun;22(2):401-23. Review.

PMID:
10385941
14.

Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.

Heidbreder CA, Hagan JJ.

Curr Opin Pharmacol. 2005 Feb;5(1):107-18. Review.

PMID:
15661634
15.

Pharmacotherapy for tobacco dependence.

Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.

Handb Exp Pharmacol. 2009;(192):487-510. doi: 10.1007/978-3-540-69248-5_17. Review.

PMID:
19184660
16.

Neuropharmacology and potential efficacy of new treatments for tobacco dependence.

Fagerström K, Balfour DJ.

Expert Opin Investig Drugs. 2006 Feb;15(2):107-16. Review.

PMID:
16433591
17.

Managing nicotine addiction.

Kotlyar M, Hatsukami DK.

J Dent Educ. 2002 Sep;66(9):1061-73. Review.

18.

Pharmacotherapy for nicotine dependence.

Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML.

CA Cancer J Clin. 2005 Sep-Oct;55(5):281-99; quiz 322-3, 325. Review.

19.

Pharmacologic treatments for the nicotine dependent smoker.

Glover ED, Glover PN.

Am J Health Behav. 2001 May-Jun;25(3):179-82. Review.

PMID:
11322615
20.

Smoking cessation treatment: pharmacogenetic assessment.

Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE.

Curr Opin Mol Ther. 2005 Jun;7(3):202-8. Review.

PMID:
15977416

Supplemental Content

Support Center